Ambu AS (OTCPK:AMBFF)
$ 19.9 -0.6 (-2.93%) Market Cap: 4.15 Bil Enterprise Value: 4.24 Bil PE Ratio: 130.11 PB Ratio: 5.45 GF Score: 96/100

Q3 2023 Ambu A/S Earnings Call Transcript

Aug 31, 2023 / 07:00AM GMT
Release Date Price: $13.51
Britt Meelby Jensen;S;CEO
Ambu A

/-

Good morning, everyone, and welcome to this Q3 2022-'23 financial results from Ambu. My name is Britt Meelby Jensen, I'm the CEO of the Company. And with me today, I have Thomas Frederik Schmidt, our CFO. So on the agenda today, I'll start going through the Q3 results with a business update, and then I'll hand over to Thomas to take us through the financials, and we will end the session today with a Q&A session.

Starting with the highlights from the Q3 this year, we have announced an 8% organic growth for the quarter, driven by a strong 23% growth in Endoscopy Solutions with Pulmonology returning to year-over-year growth and with a strong performance in Urology and ENT. We also report an EBIT margin for the quarter of 7.6%, having increased the full year outlook back in July to 5% to 6% from previous 3% to 5%.

Then I'm happy to announce a cash flow for the quarter of DKK 157 million. This drives us to an upgrade in terms of our expectations for the full year of improving the cash flow of over DKK 500 million for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot